New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 18, 2014
19:03 EDTCWH, COCO, HLF, PSUN, ADBE, NUS, EXAS, ORCLOn The Fly: After Hours Movers
NOTABLE: Oracle (ORCL), down 3.6% after reporting third earnings and revenue that missed expectations, though the company's fourth quarter profit outlook was in-line with expectations... Adobe Systems (ADBE) shares were little-changed after hours after the company's first quarter results were posted on a company website before the market close, initially sending shares higher. Adobe confirmed the results after the close and beat on both the top and bottom lines, and on its conference call, the company said second quarter profit will be in-line with expectations while revenue is expected top estimates. HIGHER: Corinthian Colleges (COCO), up 14.2% after Shah Capital, which holds a 5.64% stake in the company, sent a letter to its board outlining strategic initiatives the company should undertake, including evaluating possible sale of non-core assets and a headcount reduction... Exact Sciences (EXAS), up 8% after a clinical trial of its Cologuard test, which it co-developed with the Mayo Clinic, showed unprecedented rates of precancer and cancer detection by a noninvasive test... Pacific Sunwear (PSUN), up 9.7% after reporting earnings and revenue that were better than expected... CommonWealth REIT (CWH), up 4.8% after activist funds Corvex and Related said 81% of CommonWealth holders approve of their proposal to remove the entire board of the company. LOWER: Nu Skin (NUS), down 4.8% after disclosing in a filing with the SEC that it has received inquiries from regulators in China, which it said may result in sanctions against the company. Shares of multi-level-marketing peer Herbalife (HLF) were down 0.4% following the disclosure.
News For ORCL;ADBE;COCO;EXAS;PSUN;CWH;NUS;HLF From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
September 3, 2015
06:28 EDTADBEJudge approves $415M settlement in anti-poaching lawsuit, Reuters reports
Subscribe for More Information
September 2, 2015
10:00 EDTADBEOn The Fly: Analyst Initiation Summary
Today's noteworthy initiations include: AcelRx (ACRX) initiated with a Buy at H.C. Wainwright... Adobe (ADBE) initiated with a Perform at Oppenheimer... Antero Midstream (AM) initiated with a Buy at Ladenburg... Arbutus Biopharma (ABUS) initiated with an Outperform at JMP Securities... CSI Compressco (CCLP) initiated with a Market Perform at Wells Fargo... Cepheid (CPHD) initiated with an Equal Weight at Barclays... Cincinnati Financial (CINF) initiated with a Buy at MKM Partners... Disney (DIS) initiated with an Outperform at CLSA... Genomic Health (GHDX) initiated with an Underweight at Barclays... Green Brick (GRBK) initiated with a Neutral at Citi... Heron Therapeutics (HRTX) initiated with a Buy at BofA/Merrill... Karyopharm (KPTI) initiated with an Overweight at JPMorgan... PayPal (PYPL) initiated with a Buy at Argus... Quidel (QDEL) initiated with an Overweight at Barclays... Recro Pharma (REPH) initiated with a Buy at H.C. Wainwright.
06:20 EDTADBEAdobe initiated with a Perform at Oppenheimer
Subscribe for More Information
September 1, 2015
08:01 EDTORCLOracle granted ATO by DoD
Oracle Service Cloud has received an Authority to Operate, or ATO, from the U.S Department of Defense, or DoD, under the DoD Cloud Security Model at security impact Level 4. The Oracle Service Cloud is Oracle's premier SaaS solution providing the industry's best-in-class customer service platform for enterprise customers.
August 31, 2015
18:41 EDTADBEGoogle web browser to start limiting Adobe Flash on September 1
Google's (GOOG) "Chrome" web browser is set to start pausing Adobe (ADBE) Flash ads on September 1, preventing affected ads from playing unless a user manually clicks on the advertisment. Reference Link
August 28, 2015
07:39 EDTORCLOracle volatility elevated into Q1 and outlook
Subscribe for More Information
August 27, 2015
12:58 EDTHLFHerbalife price target raised to $100 from $90 at Pivotal Research
Subscribe for More Information
10:06 EDTORCLCiti sees Workday guidance confusion as opportunity to buy
Subscribe for More Information
August 26, 2015
15:49 EDTEXASExact Sciences says CMS advisors vote to maintain Cologuard reimbursement rate
Subscribe for More Information
06:44 EDTORCLWorkday valuation contingent on competitors in cloud market, WSJ reports
Subscribe for More Information
August 25, 2015
19:16 EDTORCLTV service Hulu to feature programmatic ads powered by Facebook, Oracle
Subscribe for More Information
09:59 EDTADBEOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
08:08 EDTADBEFireEye, Adobe among quality 'flushed out' tech names, says JPMorgan
JPMorgan analyst Sterling Auty says that market disruptions like the one seen in the last several days have historically provided a unique opportunity to invest in high-quality names and identified FireEye (FEYE), Adobe (ADBE), Veeva Systems (VEEV) and Rovi (ROVI) as four particularly interesting tech stocks that "appear flushed out" and now offer "exaggerated" risk/reward. The firm has Overweight ratings on all four stocks mentioned above after having upgraded Rovi to Overweight this morning.
08:00 EDTHLFTwitter wants to move Herbalife suit to California, NY Post reports
Subscribe for More Information
07:24 EDTORCLRentrak weakness a buying opportunity, says Brean Capital
Subscribe for More Information
06:18 EDTADBEAdobe upgraded to Outperform from Neutral at Baird
Subscribe for More Information
August 24, 2015
08:00 EDTEXASExact Sciences price target lowered to $26 from $32 at Canaccord
Canaccord lowered its price target on Exact Sciences to $26 from $32 to reflect dilution of the large secondary offering. The firm maintains its Buy rating on Exact Sciences shares, citing its sales force expansion, payer traction and a high probability of a positive outcome from the USPSTF decision.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use